Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Urinary methylmalonic acid as an indicator of early vitamin B12 deficiency and its role in polyneuropathy in type 2 diabetes.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- المصدر:
Publisher: Hindawi Limited Country of Publication: England NLM ID: 101605237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2314-6753 (Electronic) NLM ISO Abbreviation: J Diabetes Res Subsets: MEDLINE
- بيانات النشر:
Publication: <2019>-: London, United Kingdom : Hindawi Limited
Original Publication: Nasr City, Cairo : Hindawi Publishing Corporation, [2013]-
- الموضوع:
- نبذة مختصرة :
The rising incidence of diabetes and its negative impact on quality of life highlights the urgent need to develop biomarkers of early nerve damage. Measurement of total vitamin B12 has some limitations. We want to determine the levels of urinary methylmalonic acid and its relationships with serum vitamin B12 and polyneuropathy. The 176 Chinese patients with Type 2 diabetes mellitus were divided into 3 groups according to the levels of vitamin B12. A gas chromatography mass spectrometric technique was used to determine blood methylmalonic acid and urinary methylmalonic acid. The diagnosis of distal diabetic polyneuropathy was based on the determination of bilateral limb sensory and motor nerve conduction velocity and amplitude with electromyogram. Multiple regression analysis revealed that urinary methylmalonic acid/creatinine, blood methylmalonic acid, and so forth were variables that influenced diabetic polyneuropathy significantly. Nerve sensory conduction velocity and nerve amplitude in the group of urinary methylmalonic acid/creatinine >3.5 mmol/mol decreased significantly. Superficial peroneal nerve sensory and motor conduction velocity and ulnar nerve compound motor active potential amplitude were inversely correlated with urinary methylmalonic acid/creatinine. Urinary methylmalonic acid correlates with serum vitamin B12 levels in person with diabetes and is a sensitive marker of early polyneuropathy.
- References:
Arch Neurol. 2003 Sep;60(9):1296-301. (PMID: 12975298)
Am J Clin Nutr. 2003 Jul;78(1):7-21. (PMID: 12816766)
Diabetologia. 1993 Feb;36(2):150-4. (PMID: 8458529)
Neurology. 2009 Jan 13;72(2):177-84. (PMID: 19056667)
Muscle Nerve. 2003 Jul;28(1):40-5. (PMID: 12811771)
Neuroreport. 1995 Feb 15;6(3):545-8. (PMID: 7766861)
Eur J Clin Invest. 1999 Apr;29(4):321-9. (PMID: 10231344)
Ann Intern Med. 1987 May;106(5):707-10. (PMID: 3551712)
Am J Clin Nutr. 2012 Mar;95(3):686-93. (PMID: 22301932)
Clin Chem. 2004 Aug;50(8):1482-3. (PMID: 15277369)
Med Princ Pract. 2009;18(3):217-22. (PMID: 19349725)
Am J Hematol. 1990 Jun;34(2):99-107. (PMID: 2339684)
Am J Clin Nutr. 2011 Jul;94(1):359S-365S. (PMID: 21593496)
J Peripher Nerv Syst. 2005 Dec;10(4):348-53. (PMID: 16279983)
Diabetes Care. 2006 Jul;29(7):1518-22. (PMID: 16801572)
J Pharmacol Exp Ther. 1995 Dec;275(3):1124-30. (PMID: 8531072)
J Am Geriatr Soc. 1999 Sep;47(9):1158-9. (PMID: 10484267)
Lancet. 1962 Oct 27;2(7261):853-6. (PMID: 14023552)
Diabetes. 1986 Dec;35(12):1332-9. (PMID: 3770311)
Am J Clin Nutr. 2003 May;77(5):1241-7. (PMID: 12716678)
PLoS One. 2013 Apr 16;8(4):e61053. (PMID: 23613782)
Curr Opin Support Palliat Care. 2009 Jun;3(2):136-43. (PMID: 19421063)
Am J Med Sci. 1994 Nov;308(5):276-83. (PMID: 7977446)
QJM. 1998 Nov;91(11):733-7. (PMID: 10024935)
- الرقم المعرف:
0 (Biomarkers)
8LL8S712J7 (Methylmalonic Acid)
P6YC3EG204 (Vitamin B 12)
- الموضوع:
Date Created: 20140411 Date Completed: 20141028 Latest Revision: 20221207
- الموضوع:
20221213
- الرقم المعرف:
PMC3955587
- الرقم المعرف:
10.1155/2014/921616
- الرقم المعرف:
24719898
No Comments.